Shire (SHPG) Announces Receipt of Positive EMA CHMP Opinion on Revestive as SBS Treatment
Tweet Send to a Friend
Shire plc (Nasdaq: SHPG) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
